Skip to main content
logo
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
6.77
-0.26 (-3.70%)
At close: May 13, 2026, 4:00 PM EDT
6.75
-0.02 (-0.30%)
After-hours: May 13, 2026, 4:10 PM EDT

Fennec Pharmaceuticals Revenue

In the year 2025, Fennec Pharmaceuticals had annual revenue of $44.64M, down -6.09%. Fennec Pharmaceuticals had revenue of $13.78M in the quarter ending December 31, 2025, with 73.84% growth.

Revenue (ttm)
$44.64M
Revenue Growth
-6.09%
P/S Ratio
5.26
Revenue / Employee
$1,275,486
Employees
35
Market Cap
235.01M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202544.64M-2.90M-6.09%
Dec 31, 202447.54M26.29M123.69%
Dec 31, 202321.25M19.72M1,284.50%
Dec 31, 20221.54M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Arcturus Therapeutics Holdings54.71M
Voyager Therapeutics36.49M
Orchestra BioMed Holdings33.48M
Foghorn Therapeutics28.22M
LENZ Therapeutics20.99M
Alector18.42M
Adagene7.67M
Revenue Rankings

FENC News

More News